Dexras1 a unique ras-GTPase interacts with NMDA receptor activity and provides a novel dissociation between anxiety,

G C Carlson1, R E Lin2, Y Chen1

  • 1Department of Psychiatry, The Perlman School of Medicine at the University of Pennsylvania, 125 S 31st Street, Translational Research Building, Philadelphia, PA 19104, United States; Center for Neurobiology and Behavior, The Perlman School of Medicine at the University of Pennsylvania, 125 S 31st Street, Translational Research Building, Philadelphia, PA 19104, United States.

Neuroscience
|March 7, 2016
PubMed

Insights

Dexras1 knockout mice show altered working memory and sensory gating, suggesting a role in psychiatric disorders. This GTPase impacts NMDA receptor expression and may modulate specific emotional and cognitive domains.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Psychiatry

Background:

  • Dexras1 is a novel GTPase implicated in signaling pathways relevant to neurological and psychiatric diseases.
  • Previous research linked Dexras1 to iron trafficking and NMDA receptor-dependent neurodegeneration.
  • The role of Dexras1 in normal brain function and psychiatric conditions remained largely unexplored.

Purpose of the Study:

  • To investigate the function of Dexras1 in normal brain function and its potential involvement in psychiatric disease.
  • To assess behavioral abnormalities and NMDA receptor subunit expression in Dexras1 knockout mice.
  • To explore Dexras1's influence on emotional, sensory, and cognitive domains.

Main Methods:

  • Generation and behavioral phenotyping of germline knockout (KO) mice lacking Dexras1.
  • Assessment of anxiety-like behavior using open field and zero maze tests.
  • Evaluation of depression-like behavior via tail suspension test.
  • Testing of memory functions including novel object recognition and T-maze tasks.
  • Measurement of pre-pulse inhibition (PPI) and startle response.
  • Analysis of NMDA receptor subunit protein expression levels.

Main Results:

  • Dexras1 KO mice did not exhibit altered baseline anxiety or depression-like behaviors.
  • A significant decrement in working memory was observed in Dexras1 KO mice, while episodic memory remained unchanged.
  • An increase in pre-pulse inhibition (PPI) was noted, without affecting startle amplitude or locomotor activity.
  • Expression analysis revealed an increased NR2A NMDA receptor subunit in Dexras1 KO mice.

Conclusions:

  • Dexras1 plays a role in modulating specific aspects of cognitive and sensory processing, including working memory and sensory gating.
  • The observed changes in NMDA receptor subunit expression suggest a mechanism by which Dexras1 influences neuronal function.
  • These findings indicate a potential role for Dexras1 in psychiatric symptom modulation, possibly through interactions with NMDA receptors and other disease-related partners.